https://it.marketscreener.com/quotazioni/azione/BEIGENE-LTD-26123632/attualita/BeiGene-riceve-parerepositivo-del-CHMP-su-BRUKINSA-zanubrutinib-per-il-trattamento-di-adulti-a-36451614/?utm_source=telegram&utm_medium=social&utm_campaign=share